Skip to main

Early Stage Non-Small Cell Lung Cancer: New Paradigms

A Three-Part Think Tank Series - Supported by AstraZeneca

Panelists discuss the role of the thoracic surgeon before and after post-operative referrals, how referrals and the coordination of care can be improved, MDT interactions during the patient journey, and perspectives on the evolving (neo)adjuvant landscape.

The Surgeon's Role in Coordinating a Multi-Disciplinary Team

Think Tank 1


  • Jessica Donington, Chief of the Section of Thoracic Surgery at the University of Chicago


  • Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Johns Hopkins University School of Medicine
  • Jay Lee, Surgical Director of the UCLA Thoracic Oncology Program
  • Lonny Yarmus, Professor of Medicine and Oncology at Johns Hopkins University School of Medicine
Panelists discuss the roles and responsibilities of the surgeon and multi-disciplinary team during the biomarker testing process, the barriers testing, the surgeon’s role in helping to overcome such barriers, and perspectives on how to improve communication between surgeons and their patients regarding biomarker testing.

The Importance of Biomarkers and the Surgeon's Role

Think Tank 2


  • David Harpole, Thoracic Surgeon at Duke Cancer Center


  • Thomas Varghese, Chief of Thoracic Surgery at University of Utah
  • Elizabeth David, General Thoracic Surgeon at the University of Colorado Hospital
  • Jeffrey Thompson, Pulmonologist and Assistant Professor at the University of Pennsylvania
Panelists discuss potential improvements to the diagnosis and staging of patients by the multi-disciplinary team, the role of the thoracic surgeon and radiation oncologist in determining a coordinated treatment decision, management of patients with borderline-resectable Stage III NSCLC, selection of definitive CRT versus neoadjuvant therapy followed by surgery, and which specific factors impact post-operative treatment plans for patients with resectable Stage III NSCLC.

Resectability Decisions and Management of Stage III Non-Small Cell Lung Cancer

Think Tank 3


  • Mara Antonoff, General Thoracic Surgeon at the University of Texas MD Anderson Cancer Center


  • Jeff Bradley, Radiation Oncologist at the Emory University School of Medicine
  • Andreas Rimner, Radiation Oncologist at the Memorial Sloan Kettering Cancer Center
  • Daniela Molena, Thoracic Surgeon at the Memorial Sloan Kettering Cancer Center
  • Steven Lin, Physician Scientist and Radiation Oncologist at the MD Anderson Cancer Center